Myths and facts surrounding ovarian cancer
Ovarian cancer is the third most common gynaecological cancer among Indian women. The most common gynaecological cancer is breast followed […]
Ovarian cancer is the third most common gynaecological cancer among Indian women. The most common gynaecological cancer is breast followed […]
A Los Angeles jury has ordered consumer products giant Johnson & Johnson to pay $417 million in damages to a […]
Dr. Reddy’s has received an approval from US Food and Drug Administration (USFDA) for the launch of Doxorubicin Hydrochloride Liposome […]
MedGenome, a genomics-driven research and diagnostics company, on Tuesday organised a medical education session — ‘Inherited risk for breast & […]
Bolstering the knowhow behind targeted cancer treatment, Indian scientists have offered a new rationale for combination drug therapy for ovarian and breast […]
In a world today where cancer still looms large as a major threat to our health, genetic screening possibly is […]
Dr Saumya Jamuar, co-founder of Global Gene Corp and Chief of Genetics and Genomics at Boston Childrens Hospital, has developed […]
Scientists at the Duke Cancer Institute have found evidence of epigenetics at work on a genome-wide scale in cases of ovarian cancer.
Scientists at the University of Gavle and KTH Royal Institute of Technology, University of Gothenburg, are developing an electronic nose that can screen blood samples to detect ovarian cancer in its early stages.
HealthCare Global Enterprises Ltd. (HCG), South Asia